Balyasny Asset Management’s HealthStream HSTM Stock Holding History

Balyasny Asset Management’s Portfolio HSTM Stock Details HSTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-15,033	Closed	-$311K	–	3216
2026 Q1	$311K	Buy	+15,033	New	+$320K	﹤0.01%	2550
2024 Q4	–	Sell	-17,092	Closed	-$493K	–	2968
2024 Q3	$493K	Buy	17,092 +821	+5%	+$23.5K	﹤0.01%	2261
2024 Q2	$454K	Buy	+16,271	New	+$434K	﹤0.01%	2087
2023 Q4	–	Sell	-9,809	Closed	-$212K	–	2666
2023 Q3	$212K	Buy	+9,809	New	+$217K	﹤0.01%	2020
2018 Q2	–	Sell	-9,252	Closed	-$230K	–	1932
2018 Q1	$230K	Sell	9,252 -3,100	-25%	-$74.5K	﹤0.01%	1715
2017 Q4	$286K	Sell	12,352 -2,999	-20%	-$70.6K	﹤0.01%	1763
2017 Q3	$359K	Buy	+15,351	New	+$365K	﹤0.01%	1456
2016 Q2	–	Sell	-9,680	Closed	-$214K	–	1286
2016 Q1	$214K	Buy	+9,680	New	+$199K	﹤0.01%	1110

Other funds holding HSTM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Balyasny Asset Management's HSTM Position: Q2 2026 in Review

Balyasny Asset Management sold out of HealthStream (HSTM) in Q2 2026, closing a stake of 15,033 shares — an estimated $311K sold.

Balyasny Asset Management first reported a position in HSTM in Q1 2016 and held it in 8 quarters. The position peaked at $493K in Q3 2024. 219 funds tracked by Wall St. Rank hold HSTM as of Q2 2026.

Balyasny Asset Management reported no remaining HealthStream position as of Q2 2026 after selling out during the quarter.
Balyasny Asset Management sold 15,033 HealthStream shares in Q2 2026, an estimated $311K.
Balyasny Asset Management first reported a position in HealthStream in Q1 2016 and held it in 8 quarters.
Balyasny Asset Management's HealthStream position peaked at $493K in Q3 2024.
219 funds tracked by Wall St. Rank held HealthStream as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.